Patents by Inventor Sonia Moretti

Sonia Moretti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
    Publication number: 20040039054
    Abstract: The present invention provides a novel use of L-carnitine, the derivatives thereof and their pharmacologically acceptable salts in combination with antiretroviral drugs for reducing ceramide levels and enhance the activity of the aforesaid antiretroviral drugs for the therapeutic treatment of HIV-infection and AIDS.
    Type: Application
    Filed: June 17, 2003
    Publication date: February 26, 2004
    Applicant: SIGMA-TAU INDUSTRIE
    Inventor: Sonia Moretti
  • Use of basic amino acids derivatives for lowering ceramide levels
    Patent number: 6350782
    Abstract: The present invention provides methods for treating a cellular disorder in a mammal which is induced by elevated levels of ceramide by administering a basic amino acid, acylated basic amino acid, or a pharmaceutically acceptable salt thereof to effectuate lowering the ceramide levels in the mammal.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: February 26, 2002
    Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Mendes S.r.l.
    Inventor: Sonia Moretti
  • Use of basic amino acids and derivatives for lowering ceramide levels
    Patent number: 6114385
    Abstract: The therapeutic use of basic amino acids, acylated basic amino acids and their pharmacologically acceptable salts is disclosed for the treatment of a cellular disorder in a mammal which is induced by elevated levels of ceramide.
    Type: Grant
    Filed: February 3, 1998
    Date of Patent: September 5, 2000
    Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Mendes s.r.l.
    Inventor: Sonia Moretti
  • Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
    Patent number: 6040346
    Abstract: The present invention provides a novel use of L-carnitine, the derivatives thereof and their pharmacologically acceptable salts in combination with antiretroviral drugs for reducing ceramide levels and enhance the activity of the aforesaid antiretroviral drugs for the therapeutic treatment of HIV-infection and AIDS.
    Type: Grant
    Filed: February 3, 1998
    Date of Patent: March 21, 2000
    Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Mendes s.r.l.
    Inventor: Sonia Moretti
  • Use of an alkanoyl-L-carnitine for the treatment of glutamate mediated diseases
    Patent number: 6037372
    Abstract: The use of an alkanoyl-L-carnitine, e.g., acetyl-L-carnitine, or a pharmacologically acceptable salt thereof is disclosed to produce a medicament for the therapeutic treatment or prophylaxis of glutamate-mediated cytological disturbances or diseases.
    Type: Grant
    Filed: September 15, 1998
    Date of Patent: March 14, 2000
    Assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Mendes s.r.l.
    Inventor: Sonia Moretti